Dalmevin 50 mg tablete
| Name | Dalmevin 50 mg tablete |
|---|---|
| Marketing Authorisation Number | HR-H-215024398 |
| Active Substance | vildagliptin |
| Composition | svaka tableta sadrži 50 mg vildagliptina |
| Pharmaceutical Form | tableta |
| Packaging [MA Number for Packaging] | 7 tableta u blisteru, u kutiji [HR-H-215024398-01] 14 tableta u blisteru, u kutiji [HR-H-215024398-02] 28 tableta u blisteru, u kutiji [HR-H-215024398-03] 30 tableta u blisteru, u kutiji [HR-H-215024398-04] 56 tableta u blisteru, u kutiji [HR-H-215024398-05] 60 tableta u blisteru, u kutiji [HR-H-215024398-06] 90 tableta u blisteru, u kutiji [HR-H-215024398-07] 112 tableta u blisteru, u kutiji [HR-H-215024398-08] 180 tableta u blisteru, u kutiji [HR-H-215024398-09] 336 tableta u blisteru, u kutiji [HR-H-215024398-10] |
| Manufacturer | Medochemie Ltd., Limassol, Cipar |
| Marketing Authorisation Holder | Medochemie Ltd., Constatinoupoleos Str. 1-10, Limassol, Cipar |
| Marketing Authorisation Date | 07.01.2022 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/21-02/140 |
| Registration Number | 381-12-01/38-22-04 |
| Prescription | na recept |
| Type of prescription | ponovljivi recept |
| Distribution | u ljekarni |
| Advertising to general public | zabranjeno |
| ATC Code | A10BH02 |
| Medicinal product marketed in the Croatia | Da |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
